Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2017

Jan 4, 2017

29777_dirs_2017-01-04_24564577-54f1-440b-9e76-4b515de65336.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2016-12-31

Reporting Person: LIDDY EDWARD M (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-12-31 Stock Equivalent Units $0 A 859 Acquired Common shares (859) Direct

Footnotes

F1: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F2: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.